Vaping illness death count surpasses 50 in US

Vaping illness death count surpasses 50 in US
In this Saturday, June 8, 2019, file photo, two women smoke cannabis vape pens at a party in Los Angeles. On Thursday, Dec. 12, 2019, U.S. health officials said 26 states have reported deaths, for a total of 52. (AP Photo/Richard Vogel, File)

The death toll in the vaping illness outbreak has topped 50, U.S. health officials said Thursday.

The 52 deaths in 26 states are among the 2,409 hospitalized that have been reported across the nation this year, the Centers for Disease Control and Prevention said.

Hospitalized cases have been most common in the Midwest, with some of the highest rates in Illinois, Indiana, and Wisconsin.

The median age of the people who died is 52, but most people who suffered have been much younger, with half in their teens or early 20s.

The outbreak appears to have started in March. The bulk of the cases occurred in August and September, but new cases are still being reported, including 118 in the past week, the CDC said.

Some of the newly reported illnesses happened more than a month ago but were only recently reported. However, 43 percent of the latest batch of cases were people hospitalized since Nov. 17, the agency said.

Most patients have said they vaped products containing THC, the ingredient that produces a high in marijuana. CDC officials have gradually come to focus their investigation on black-market THC cartridges.

Last month, CDC officials said they had narrowed in on a culprit—a called vitamin E acetate that has been commonly found in the lungs of sick patients and in the products they vaped. It's a thickening agent that's been added to illicit THC vaping liquids.


Explore further

Officials list pot vape brands reported in US outbreak

© 2019 The Associated Press. All rights reserved.

Citation: Vaping illness death count surpasses 50 in US (2019, December 12) retrieved 28 February 2020 from https://medicalxpress.com/news/2019-12-vaping-illness-death-surpasses.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments